Market Currents
OraSure Technologies (OSUR) +35.3% premarket after an FDA advisory panel's recommendation to let...
-
Wednesday, May 16, 2012, 8:10 AM ETOraSure Technologies (OSUR) +35.3% premarket after an FDA advisory panel's recommendation to let an HIV test be sold in retail stores; test results could be obtained in the home like tests for pregnancy and blood sugar. The panel voted in favor 17-0 twice, on potential benefits outweighing potential risks and on safety and effectiveness. (also)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
